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Abstract
Previous studies have suggested that sugars enhance iron bioavailability, possibly through either chelation or altering the
oxidation state of the metal, however, results have been inconclusive. Sugar intake in the last 20 years has increased
dramatically, and iron status disorders are significant public health problems worldwide; therefore understanding the
nutritional implications of iron-sugar interactions is particularly relevant. In this study we measured the effects of sugars on
non-heme iron bioavailability in human intestinal Caco-2 cells and HepG2 hepatoma cells using ferritin formation as a
surrogate marker for iron uptake. The effect of sugars on iron oxidation state was examined by measuring ferrous iron
formation in different sugar-iron solutions with a ferrozine-based assay. Fructose significantly increased iron-induced ferritin
formation in both Caco-2 and HepG2 cells. In addition, high-fructose corn syrup (HFCS-55) increased Caco-2 cell iron-
induced ferritin; these effects were negated by the addition of either tannic acid or phytic acid. Fructose combined with
FeCl3 increased ferrozine-chelatable ferrous iron levels by approximately 300%. In conclusion, fructose increases iron
bioavailability in human intestinal Caco-2 and HepG2 cells. Given the large amount of simple and rapidly digestible sugars in
the modern diet their effects on iron bioavailability may have important patho-physiological consequences. Further studies
are warranted to characterize these interactions.
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Introduction
Evidence that simple sugars such as glucose and fructose affect
iron bioavailability first arose in the 1960s from work showing that
sugars were able to chelate inorganic iron and form stable, low
molecular weight soluble complexes [1]. These sugar-iron
complexes were readily absorbed across the intestinal mucosa of
rodent models [2,3]. Given that intake of fructose and sucrose has
increased dramatically worldwide in the past 40 years, especially in
the Western world, while at the same time iron deficiency and iron
excess remain significant public health concerns [4–6], under-
standing the nutritional implications of iron-sugar interactions is
particularly relevant.
Excess sugar is blamed for a myriad of modern health problems,
but whether sugars might actually be protective against iron
deficiency, or contribute to either total body or cellular iron
overload is unknown. Insufficient body iron levels are associated
with significant health consequences, and approximately 2 billion
people suffer from iron deficiency. Furthermore, iron overload
related to either primary (e.g. hereditary hemochromatosis) or
secondary (e.g. beta-thalassemia) abnormalities in iron metabolism
is prevalent in many populations [6,7]. There is also interest in the
role that disordered regulation of intracellular iron levels plays in
the pathogenesis of several non-communicable diseases including
non-alcoholic fatty liver disease (NAFLD) [8,9].
Absorption of non-heme iron begins with iron uptake into the
enterocyte by Divalent Metal Transporter 1 (DMT1); DMT1
takes up ferrous iron (Fe2+) ([10,11], reviewed by Montalbetti et al,
[12]). Non-heme iron, however, is primarily in the oxidized ferric
form (Fe3+) thus it must be reduced to be absorbed; reduction
occurs either via the apical membrane bound ferrireductase
Duodenal cytochrome b (Dcytb), or through reducing agents such
as ascorbate [13]. Dietary factors can change non-heme iron
bioavailability by altering iron solubility or oxidation state.
Non-heme iron is the main source of iron in the diet [14] and its
bioavailability is influenced by a range of dietary factors. Studies
investigating the influence of sugars on iron bioavailability have
yielded conflicting results; although a number of studies demon-
strated improved iron bioavailability [15–20], others found either
no effect [21,22], or decreased absorption [23,24]. Human studies
have been few, small (number of subjects ranged from 8–25 in the
above cited studies), of short duration [17,23], and with limited
information on iron status and hereditary iron metabolism defects
[15,22,23].
The most consistent finding regarding mono- and di-saccharides
and iron is that fructose increases dietary non-heme iron
absorption, possibly by chelating and/or reducing iron to the
ferrous form [25]. Whilst the dietary burden of fructose alone is
low, consumption of sucrose (a glucose-fructose disaccharide
cleaved into its constituent sugars prior to absorption), and high
fructose corn syrup (HFCS, a widely used liquid sweetener), is high
[26–28]; consequently fructose levels in both the gut and portal
vein may be elevated. It is thus vital to clarify the effect of sugars
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and sweeteners on iron bioavailability in the gut and liver, as this
could have an impact on iron status, particularly in population
groups at risk of iron overload.
The objective of the current study was to investigate the effects
of the sugars fructose, glucose and sucrose, as well as high fructose
corn syrup 55 (HFCS-55, a mixture of fructose and glucose
monomers in a 55:45 ratio), on non-heme iron bioavailability
using the Caco-2 cell in vitro digestion model. Furthermore, as the
modern diet delivers a loaded cocktail of sugars and iron to the
liver, and fructose may be used in studies to induce hepatic
metabolic changes, the effect of sugars on liver iron absorption was
evaluated using the liver-derived HepG2 cell line. The in vitro
digestion Caco-2 cell model is an established tool for assessing gut
iron bioavailability and has been validated by comparison with
data from human studies [29], and HepG2 cells have been used to
measure liver iron uptake [30]. Ferritin formation in both cell lines
correlates with increasing concentration of iron treatments [31–
33]. The use of ferritin as an indicator of iron availability was
pioneered by Glahn et al, [34] and it is now widely used as a
surrogate marker for iron uptake (for recent examples see [35–
38]).
Materials and Methods
Reagents
Unless otherwise stated, reagents were purchased from Sigma-
Aldrich, UK. Glassware used in sample preparation and analyses
was treated with 10% (v/v) concentrated Nitric acid (68%) for 24 h
and rinsed with 18 MV purity water. All water used in
experiments was18 MV purity.
Cell culture
The Caco-2 TC7 cell clone, developed by Monique Rousset
and colleagues [39,40], was kindly gifted to the Sharp lab and was
used in experiments at passages 44 – 49. Cells were maintained in
cell culture treated T75 flasks (Corning Inc., Costar) and
subcultured every 5–7 days. Cells were grown in Dulbecco’s
Modified Eagle Medium (DMEM, Gibco, 41965) supplemented
with 10% v/v fetal bovine serum (LCG Standards, 30-2020), 1%
penicillin-streptomycin, 4 mmol/L L-glutamine, 1% non-essential
amino acids, and Plasmocin 5 mg/ml (Source Bioscience). For
experiments, Caco-2 cells were seeded at 16104 cells/cm2 in six-
well plates (Corning Inc., Costar) and used 13-15 days post seeding
as per the protocol used in the Glahn lab [34]; at this stage DMT1
protein levels and iron uptake are maximal in the Caco-2 TC7 cell
line [41].
HepG2 cells were obtained at passage 28 from American Type
Culture Collection and used in experiments at passages 30–40;
cells were maintained in cell culture treated T75 Tissue Culture
Flasks seeded at a density of 16105 cells/cm2 and sub-cultured
every 48 – 72 hours. Cells were grown in DMEM supplemented
with heat inactivated 10% v/v fetal bovine serum, 1% penicillin-
streptomycin, 2 mmol/L glutamine, 1% non-essential amino
acids. Experiments with HepG2 cells were carried out in cell
culture treated six-well plates seeded at 16105 cells/cm2 and used
24- 48h post seeding.
24 hours prior to all experiments (Caco-2 & HepG2) DMEM
medium was removed and the cell culture wells washed with
2.0 ml Minimal Essential Medium (MEM, Gibco, 31095); growth
medium was then changed to MEM supplemented with 10 mmol/
L PIPES (piperazine-N, N’-bis- [2-ethanesulfonic acid]), 1%
antibiotic/ antimycotic solution, 11 mmol/L hydrocortisone,
0.87 mmol/L insulin, 0.02 mmol/L sodium selenite (Na2SeO3),
0.05 mmol/Ltriiodothyronine and 20 mg/L epidermal growth
factor. Fetal bovine serum (FBS) free media was used because
different batches of FBS have differing levels of iron and other
factors that could add confounding variables; MEM was
supplemented to ensure optimal Caco-2 cell growth and differen-
tiation in the absence of FBS while maintaining iron levels, 8 mg
Fe/L [34] [42].
Caco-2 cell - in vitro digestion studies
Sugar solutions. All solutions were freshly made on the day of
the experiment. Stock solutions of 1 mol/L fructose, glucose or
sucrose were prepared in 140 mmol/L NaCl, 5 mmol/L KCl,
pH 2 solutions. In addition, HFCS-55 (a kind gift from Hanse-
land, Groningen, Holland) was diluted with water to produce a
1 mol/L fructose stock solution and then shaken with 4 g Chelex
100 resin (Bio-Rad Laboratories, 142-2832) for half an hour to
remove possible metal contaminants, followed by elution through
a 1.6 cm diameter filtration column (VWR). Iron levels in the
Chelex treated HFCS stock solutions were checked by Inductivity
Coupled Plasma-Optical Emission Spectrometer and were ,
5 mmol/L; iron levels in blank, no food digests were also ,
5 mmol/L. Sugar concentrations were selected to be within the
range that might occur in the gut after a meal (after dilution
through the in vitro digestion). All solutions were filter sterilized
prior to cell culture application.
The in vitro digestion followed a modified version of the
protocol developed by Glahn et al [43]. All digestion solutions
were prepared fresh for each experiment. On the first day of the
experiment the cells were washed with 2.0 ml MEM and 1.0 ml
supplemented MEM was added to each individual plate well.
Food samples were prepared as follows: 25 mg of Fe (added as
Fe solubilized in 1% HCL, High-Purity Standards, 100026-2) and
1.0 mL of stock sugar solutions were added to 10 ml 140 mmol/L
NaCl, 5 mmol/L KCl pH 2 solutions in sterile 50 ml polypro-
pylene centrifuge tubes. The ratio of iron:sugar < 1:2000 was
based on expected relative values of the two nutrients in the gut.
Reference control samples of 25 mg Fe added to 11 ml 140 mmol/
L NaCl, 5 mmol/L KCl, pH 2 solutions alone, as well as positive
controls consisting of 25 mg Fe added to 11 ml 140 mmol/L NaCl,
5 mmol/L KCl, pH 2 solutions containing 265 mmol/L ascorbate
were performed with each replication. The positive controls’
iron:ascorbate ratio was chosen to reflect typical relative levels that
might occur in a meal. To ensure no iron contamination of the
system ‘‘no food digest’’ samples consisting simply of 140 mmol/L
NaCl, 5 mmol/L KCl, pH 2 solutions were included with each
experiment. Finally, solutions of 140 mmol/L NaCl, 5 mmol/L
KCl, pH 2 containing 1 ml of stock sugar solutions without
extraneous iron were tested to ensure that sugars alone did not
increase ferritin formation. In some experiments, known inhibitors
of iron bioavailability, phytic acid and tannic acid, were added to
the food digests.
The peptic phase of digestion was initiated by the addition of
0.5 ml pepsin solution (Chelex purified) to each food sample
(herein referred to as digests or food digests). The pH was
readjusted to pH 2.0 with 1 mol/L HCL and the samples were
shaken in a New Brunswick Orbital shaker at 376C, 200 RPM, for
75 minutes. This phase was terminated with the addition of
1 mol/L NaHCO3 and subsequent pH increase to , pH 5.5.
The intestinal digestion phase was initiated with the addition of
2.5 ml Chelex-purified bile/pancreatin solution with subsequent
adjustment of the pH to pH 6.9 – 7.0 with 1 mol/L NaHCO3. All
food digests were then brought to a final volume of 15 ml by the
addition of 140 mmol/L NaCl, 5 mmol/L KCl solution, pH 6.9.
1.5 ml aliquots of digests were gently pipetted into the upper
chamber of each cell culture plate well; the upper chamber was
Fructose, Iron and the Gut
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created by the fitting of a 15,000 Da molecular weight cutoff
dialysis membrane (Tubing Spectra/Por 7 dialysis membrane,
Fisher Scientific) to a Transwell tissue culture treated insert ring
(Fisher Scientific; the necks of the rings were shortened by 0.1 mm
to remove the original filter and prevent excessive pressure on the
cell monolayer) held in place with a silicone ring (Parker 2-023
S0613, WebSeal Inc.). Plates were then covered and placed on a
platform fitted Multi-function 3D rotator (Fisher Scientific PS-
M3D) set at 6 oscillations per minute in a 376C incubator with a
5% CO2/95% air atmosphere at constant humidity for 120
minutes.
After the 120 min incubation the inserts were removed and an
additional 1.0 ml of supplemented MEM was added to each cell
culture plate well. Plates were returned to the incubator for a
further 22 hours; after this period cells were harvested for analysis
of cell ferritin content.
Six replicates of each sugar were tested per experiment, and
each experiment was repeated at 3 separate times.
Fructose Analysis. Levels of fructose in prepared fructose
solutions and HFCS-55, before and after Chelex treatment, were
determined using high performance liquid chromatography
(HPLC) with refractive index detection using water/methylated
spirit extraction method with modifications for high salt levels.
Premier Analytical Services, accredited by the United Kingdom
Accreditation Service (UKAS), Buckinghamshire, UK, carried out
the analysis.
Measurement of iron in blank no-food-digests and HFCS-
55 by ICP-OES
Aliquots of the HFCS-55 Chelex treated stock solutions and
blank digests were subjected to microwave digestion using an
accelerated reaction system (CEM MARS 5H with XP-1500
vessels). 0.5 ml of the solutions (in triplicate) was added to 5.0 ml
concentrated 68% trace analysis grade nitric acid (Fisher). The
samples were heated for 20 minutes at 400-psi pressure and 1200-
W power. Iron levels were quantitatively analyzed by Inductivity
Coupled Plasma-Optical Emission Spectrometer (ICP-OES,
Perkin Elmer Optima 4300 DV).
HepG2 cell studies
HepG2 cells were treated for 24 h with MEM containing
1 mmol/L ferric ammonium citrate (FAC) and either 15 mmol/L
glucose (inclusive of the 5 mmol/L glucose contained in MEM) or
1 – 15 mmol/L fructose. Cells treated with MEM with 1 mmol/L
FAC alone served as a reference in each experiment; in addition,
1 mmol/L FAC + 100 mmol/L ascorbate, and MEM alone treated
cells were positive and negative controls, respectively. HepG2 cells
were also treated with fructose in the absence of any added iron to
ensure that fructose alone did not increase ferritin formation
unrelated to iron uptake. After 24 hours cells were harvested for
analysis of cell ferritin content.
Ferritin analysis
At the end of each experiment, medium was removed from the
wells and cells were rinsed twice with ice cold Phosphate Buffered
Saline (PBS). 200 ml ice cold CelLytic with 1% protease inhibitor
was added to each well, and cell monolayers were removed with a
cell scraper and placed in 1.8 ml Eppendorf tubes. Tubes were
shaken for 15 minutes on a Stuart microtitre plate shaker at 1250
RPM and then spun at 6,000 g for 6 minutes in a 5804R
Eppendorf centrifuge. The supernatant was aspirated and stored
at –806C until analysis.
Ferritin analysis using SpectroFerritin MT Enzyme Linked
Immunoassay (ELISA; RAMCO) was carried out on cell
extraction supernatants. Absorption readings were performed at
492 nm with subtraction for background at 620 nm in a Thermo
Multiscan Ascent Spectrophotometer.
Protein concentration in each sample was measured using the
Pierce Protein BCA Assay (Fisher Scientific, 23227). Using this
method protein concentrations were consistently 5.0–6.5 mg/ml
or 1.0–1.3 mg/well; these are the levels typically found in our lab
on day 14 with an initial Caco-2 cell seeding density of
16104 cells/cm2 (as recommended by ATCC).
Effect of sugars on iron reduction in vitro
The ferrozine assay is generally used to measure ferrous iron
levels in biological samples, and has specifically been used to
measure iron in cell extracts [44]. It may also, in adapted form, be
used to measure ferrous iron in non-biological samples such as
intravenous iron sucrose solutions (Venefor) [45]. In our studies
the ferrozine assay was adapted to measure ferrous iron formation
in solution after incubation of ferric chloride with fructose, or
glucose, or sucrose. The lower limit of detection of the assay is
10 mmol/L; to ensure that production of Fe2+ was within the
detection limits of the assay we increased levels of iron and sugar in
the test tube by a factor of 10 (i.e. 100 mmol/L FeCl3; 500 mmol/
L sugar) while maintaining the same molar ratio (1:50).
Carbohydrate solutions containing 500 mmol/L glucose, fructose,
or sucrose were prepared in PBS; ferric chloride was added to give
a final concentration of 100 mmol/L Fe3+. 150 ml ferrozine
reagents (containing 32 mg ferrozine, 32 mg neocuprine and
3.8 g ammonium acetate dissolved in 10 ml water) were mixed
with 400 ml carbohydrate solutions. The samples were incubated
for two hours at 376C degrees in a 96 well culture plate. The
standard calibration curve was made up with freshly prepared
ferrous ammonium sulfate. Absorption readings were performed
at 550 nm on a Bio-TekSynergy HT Spectrophotometer.
Statistical analysis
Statistical analysis of the data was performed using GraphPad
Prism (v.6.0 GraphPad Software, San Diego, CA). Statistical
analysis was conducted according to the methods of Motulsky
[46]. Where noted data from separate experiments were
normalized to the relevant reference control. To compensate for
unequal variance, GraphPad Prism was used to log transform
data. Data are presented as means 6 S.E.M. Except as otherwise
noted, data were analyzed by one-way ANOVA followed by
Tukey’s post-hoc test for pairwise comparisons of experimental
groups. Differences between means were considered significant at
p # 0.010.
Results
Effect of sugars on cell ferritin formation
The effect of sugars on iron bioavailability was assessed by
incubating Caco-2 cells with digests of sugar solutions containing
iron. Fructose increased iron-induced ferritin formation in Caco-2
cells by approximately 40% (Figure 1). In contrast, ferritin levels
were not altered in cells exposed to iron plus either glucose or
sucrose. In addition, incubation with digests of HFCS-55 increased
iron-induced ferritin levels by approximately the same amount as
fructose (Figure 2). Incubation with sugars alone (i.e. in the
absence of iron) did not increase ferritin formation (data for
glucose and sucrose not shown). Fructose levels in stock fructose
solutions, and in stock HFCS-55 solutions after Chelex treatment,
Fructose, Iron and the Gut
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were on average 1 mol/L 6 0.01 (SEM) and 0.99 mol/L 6 0.04
(SEM), respectively.
Effect of inhibitors of iron bioavailability on sugar-
induced ferritin formation
To determine whether known inhibitors of iron bioavailability
could influence the enhancing effect of fructose and HFCS-55 on
iron-induced ferritin formation, cells were incubated with either
tannic acid (TA) or phytic acid (PA). Incubation with TA or PA
alone did not alter basal cell ferritin levels (Figures 3 & 4). TA
(1Fe:1TA molar ratio; Figure 3) and PA (1Fe:10PA molar ratio;
Figure 4) both decreased iron bioavailability. Furthermore,
addition of TA (Figure 3) or PA (Figure 4) to fructose- and
HFCS-55-iron digests significantly decreased the sugar-iron-
induced increase in ferritin formation to the level of ‘‘no food
digests.’’
Effects of sugars on ferrous iron formation in vitro
It has been reported previously that sugars may have weak iron
reducing and chelating activity [1,25]. Therefore, to determine
whether sugar solutions increased iron bioavailability via in vitro
reduction of Fe3+ to Fe2+, we used the ferrozine assay that
selectively detects ferrous iron. Fructose significantly increased
ferrozine-chelatable ferrous iron levels by approximately 300%
(Figure 5). There was no effect of glucose, sucrose or mannitol on
Fe2+ formation. FeCl3 alone in MEM gave rise to the lowest levels
of ferrozine-chelatable ferrous iron, with levels only 22% of those
formed in the presence of fructose.
Effect of fructose on HepG2 cell ferritin formation
To determine whether fructose or glucose might also influence
hepatic iron-induced ferritin formation HepG2 cells were exposed
to increasing concentrations of fructose, or glucose, and iron. In
Figure 1. Sugar digests effects on iron-induced ferritin.
Measurement of Caco-2 cell ferritin formation from digests of Fe and
solutions of sucrose (Sucrose+Fe) or glucose (Glucose+Fe) or fructose
(Fructose+Fe) at an iron:sugar ratio of < 1:2000. Equal amounts of iron
(25 mg) were combined with sugar solutions (1.0 mL) and subjected to
the Caco-2 in vitro digestion process. Digests with fructose alone and
no added Fe (No Food Digest) were used as negative controls; digests
with Fe alone (Fe) and Fe plus ascorbic acid (Fe + AA) were used as
reference controls and positive controls, respectively. Values are means
of data normalized to 10 ng of ferritin/mg protein in the reference
control (Fe)6 SEM, n$15. Based on an ANOVA (p,0.0001) with Tukey’s
multiple comparisons test post-hoc analysis done on an all-pairwise
basis, bar values with no letters in common are significantly different (p
# 0.010).
doi:10.1371/journal.pone.0083031.g001
Figure 2. Effect of high-fructose corn syrup (HFCS) digests on
iron-induced ferritin. Measurement of Caco-2 cell ferritin formation
from digests of Fe and fructose (Fructose+Fe), or Fe and HFCS-55
(HFCS+Fe) at an iron:fructose ratio of < 1:2000. Equal amounts of iron
(25 mg) were combined with fructose solutions (1.0 mL) and subjected
to the Caco-2 in vitro digestion process. Digests with HFCS alone and
no added Fe (No Food Digest) were used as negative controls; digests
with Fe alone (Fe) and Fe plus ascorbic acid (Fe + AA) were used as
reference controls and positive controls, respectively. Values are means
of data normalized to 10 ng of ferritin/mg protein in the reference
control (Fe) 6 SEM, n $ 18. Based on an ANOVA (p,0.0001) with
Tukey’s multiple comparisons test post-hoc analysis done on an all-
pairwise basis, bar values with no letters in common are significantly
different (p # 0.010).
doi:10.1371/journal.pone.0083031.g002
Figure 3. Effect of tannic acid (TA) and fructose, or TA and
high-fructose corn syrup (HFCS), on iron-induced ferritin
formation. Measurement of Caco-2 cell ferritin formation from digests
of Fe and fructose (Fructose+Fe), or HFCS-55 (HFCS+Fe), at an
iron:fructose ratio of < 1:2000, plus tannic acid at a 1:1 molar ratio of
Fe:TA. Equal amounts of iron (25 mg) were combined with sugar
solutions (1.0 mL) and TA and subjected to the Caco-2 in vitro digestion
process. Digests without TA are shown with lighter shading and digests
with TA added are shown with darker shading. Values are means of data
normalized to 10 ng of ferritin/mg protein in the reference control (Fe)
6 SEM, n(Fe+AA+TA) = 4, n(TA alone) = 6, all other n = 18. Analysis of
Figure 3A was based on a two-factor ANOVA (p,0.0001) with Tukey’s
multiple comparisons test post-hoc analysis done on an all-pairwise
basis, bar values with no letters in common are significantly different (p
# 0.010). Analysis of Figure 3B was based on a one-factor ANOVA
(p,0.0001) with Tukey’s multiple comparisons test post-hoc analysis
done on an all-pairwise basis, bar values with no letters in common are
significantly different (p # 0.010).
doi:10.1371/journal.pone.0083031.g003
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Figure 4. Effect of phytic acid (PA) and fructose, or high-fructose corn syrup (HFCS), on iron-induced ferritin formation.Measurement
of Caco-2 cell ferritin formation from digests of Fe and fructose (Fructose+Fe), or HFCS-55 (HFCS+Fe), at an iron:fructose ratio of< 1:2000, plus phytic
acid at 1:1, 1:5 or 1:10 Fe:PA molar ratios. Equal amounts of iron (25 mg) were combined with sugar solutions (1.0 mL) and PA and subjected to the
Caco-2 in vitro digestion process. Digests of the above without the addition of PA are provided for reference. Digests with Fe alone (Fe), PA alone (PA
Alone), and Fe plus PA (1Fe:10PA) were used as controls. Values are means of data normalized to 10 ng of ferritin/mg protein in the reference control
(Fe) 6 SEM, n(Fe+PA1:10) = 3, all other n $ 6. Analysis of Figure 4A was based on a two-factor ANOVA (p,0.0001) with Tukey’s multiple comparisons
test post-hoc analysis done on an all-pairwise basis, bar values with no letters in common are significantly different (p# 0.010). Analysis of Figures 4B
and 4C was based on a one-factor ANOVA (p,0.0001) with Tukey’s multiple comparisons test post-hoc analysis done on an all-pairwise basis, bar
values with no letters in common within Figure 4B are significantly different (p # 0.010) and similarly bar values with no letters in common within
Figure 4C are significantly different (p # 0.010).
doi:10.1371/journal.pone.0083031.g004
Figure 5. Carbohydrate effect on release of ferrozine-
chelatable ferrous iron (Fe2+) in vitro. 50 mmol/L solutions of
glucose, fructose, sucrose or mannitol were prepared with the addition
of FeCl3 at a final concentration of 0.1 mmol/L. Solutions with iron
alone and iron plus ascorbate were used as controls. Analysis for
ferrozine-chelatable ferrous iron was performed after 2 hours incuba-
tion. Data in each column are presented as the mean 6 SEM, n= 12 per
group. Analysis was based on a one-factor ANOVA (p= 0.0001). Post-
hoc analysis was done versus control. Fructose at a concentration of
50 mmol/L significantly increases ferrous iron levels in comparison to all
other tested carbohydrate solutions; p , 0.0001, compared with
0.1 mmol/L FeCl3 alone.
doi:10.1371/journal.pone.0083031.g005
Figure 6. HepG2 iron-induced ferritin in response to carbohy-
drate treatments. Measurement of HepG2 cell ferritin formation
following treatment for 24 hours with 1 mmol/L ferric ammonium
citrate (FAC) and one of the following: 15 mmol/L glucose (Glucose+
FAC); 15 mmol/L glucose and 15 mmol/L fructose (Fructose
+Glucose+FAC); 15 mmol/L fructose (Fructose+FAC). Cells treated with
MEM alone (MEM), or fructose alone (Fructose Only), without the
addition of FAC, were used as negative controls. Cells treated with
0.1 mmol/L ascorbate and 1 mmol/L FAC were used as positive controls.
Values are means of data normalized to 400 ng of ferritin/mg protein in
the reference control (MEM+FAC) 6 SEM, n(MEM) = 4, n(Fructose
Only) = 6, all other n $ 12. Based on an ANOVA (p,0.0001) with
Tukey’s multiple comparisons test post-hoc analysis done on an all-
pairwise basis, bar values with no letters in common are significantly
different (p # 0.010).
doi:10.1371/journal.pone.0083031.g006
Fructose, Iron and the Gut
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the presence of iron, liver ferritin levels were unaffected by co-
addition of glucose; however, fructose increased iron-induced
HepG2 cell ferritin by approximately 35% - maximal ferritin
formation was observed with 15 mmol/L fructose (Figures 6 &7).
There was no effect of fructose alone on ferritin formation (Figure
6).
Discussion
Non-heme iron bioavailability is influenced by many dietary
factors. This study suggests that fructose increases iron bioavail-
ability in our in vitro cell models of the gut and liver. These results
are consistent with previous work in rodent models in which iron-
fructose solutions increased both gut iron absorption [18] and liver
iron deposition [47].
Recent human intervention trials looking at the effects of
fructose on iron uptake are lacking, but there have been several
epidemiological studies that analyzed fruit intake and iron status.
Fruit is a dietary source of fructose; observational studies of fruit as
a modifier of iron status have yielded conflicting results. Milward
et al carried out a study in subjects with hereditary hemochro-
matosis (HH), which found that non-citrus fruit intake was
protective against iron overload [48]. In contrast, Fleming et al
found that fruit intake was associated with an increased risk for
elevated iron stores in the Elderly Framingham Heart Study
cohort [49]. The different results are most likely secondary to
several factors. The study by Milward et al differentiated between
citrus fruits (which are rich sources of citric and ascorbic acid,
known enhancers of iron uptake), and non-citrus fruit; Fleming et
al did not differentiate between fruit types. In addition, Milward et
al only studied subjects with HH, whereas HH was one of the
exclusion criteria for the Framingham study. Another possible
confounding factor is that fruits have varying levels of phytates and
polyphenols; the results of our study suggest that fructose in fruit
would not alter iron bioavailability as both phytate and the
polyphenol tannic acid inhibited the effects of fructose on iron
bioavailability.
In Western diets and increasingly worldwide, however, the
major source of fructose in the diet is not fruit, but sucrose and
high-fructose corn syrup, and in particular HFCS-55 [27,50]. In
the United States of America HFCS represents 15–20% of total
energy intake, the majority coming from sugar sweetened
beverages (SSB) [51]. Here, we investigated the effect of HFCS-
55 on iron bioavailability, and demonstrated increased ferritin
formation in the Caco-2 cell system. Few studies have investigated
the effects of sugars from SSB on iron bioavailability. A small study
by Hallberg et al found that a low pH cola drink increased iron
absorption; however, this was attributed to the low pH of the
beverage and data on the carbohydrate composition of the
beverage is unavailable [52]. A more recent study, which
specifically looked at the effect of beverage carbohydrate on iron
bioavailability by comparing regular cola with artificially sweet-
ened diet cola, found no effect on iron absorption from either
source [53]. However, cola drinks contain between 0.5 –
0.7 mmol/L caffeine [54], a polyphenol shown to decrease non-
heme iron bioavailability in multiple studies and thus a possible
confounding factor when assessing SSB sugar effects on iron
bioavailability [55,56]. In our study HFCS-55, used at a
concentration comparable to that found in sweetened beverages,
significantly increased iron bioavailability and the effect was
comparable to that observed with fructose.
The other sugars tested in this study did not influence iron
bioavailability and this is consistent with previous work showing no
effects of sucrose or glucose on iron absorption [18]. One might
have predicted that the fructose released from digestion of sucrose
would increase iron uptake. However, there are suggestions in the
literature that sucrose-derived fructose is taken up by the
enterocyte immediately upon hydrolysis; it would therefore not
be available to interact with iron, in comparison with HFCS which
upon ingestion yields free fructose monomers in the intestinal
lumen [57].
It has been proposed that fructose increases iron bioavailability
by increasing ferrous iron formation [25]. Our observation that
fructose significantly increased ferrozine-chelatable ferrous iron
levels is consistent with this mechanism. Fructose is a reducing
sugar giving positive tests for both Benedicts and Fehlings
reagents; in solution it exists primarily in the furanose form but
is in equilibrium with the straight chain and pyranose forms [58].
Interestingly, in basic solution fructose is a stronger reducing agent
than aldoses such as glucose [59]. Sucrose is not a reducing sugar
because neither of its carbonyl groups are available to participate
in redox reactions [60].
Work by Stitt et al looking at sugar effects on iron bioavailability
analyzed iron levels in the liver, as well as gut iron uptake; iron co-
administered with fructose resulted in both increased iron
absorption and liver iron deposits [47]. In addition, a recent
study using mice found that a high-fructose/high-fat diet increased
iron liver levels [61]. These observations are consistent with our
findings that HepG2 ferritin levels increased in cells treated with
iron and fructose. Data on human blood fructose levels are limited,
and there is even less information on human portal vein fructose
concentrations to which the liver would be exposed. However, a
recent study using an enzyme-based assay, validated by gas
chromatography-mass spectroscopy, reported circulating serum
post-prandial fructose levels up to 16 mmol/L [62]; if these values
are correct then portal vein fructose levels would be predicted to
be in the order of 27 - 53 mmol/L as the liver extracts 40–70% of
portal vein fructose [63]. Older studies in animals, and several
small studies in humans, have reported portal vein fructose levels
Figure 7. Fructose dose response on HepG2 cell iron-induced
ferritin. Measurement of HepG2 cell ferritin formation following
treatment for 24 hours with 1 mmol/L FAC and one of the following:
1 mmol/L fructose (1 mM Fruc+FAC); 5 mmol/L fructose (5 mM Fruc +
FAC); 15 mmol/L fructose (15 mM Fruc + FAC), to determine dose
response of HepG2 cell ferritin relative to fructose concentration. Values
are means of data normalized to 400 ng of ferritin/mg protein in the
reference control (MEM+FAC) 6 SEM, n $ 6. Based on an ANOVA
(p,0.0001) with Tukey’s multiple comparisons test post-hoc analysis
done on an all-pairwise basis, bar values with no letters in common are
significantly different (p # 0.010).
doi:10.1371/journal.pone.0083031.g007
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varying from 1 – 2.2 mmol/L [63–67]. The fructose concentra-
tions used in our studies lie somewhere in the middle of these two
extremes of possible post-prandial portal circulation levels.
A number of studies have used either high fructose or HFCS
diets to augment the effects of a high fat diet on liver metabolism,
in order to study the development of fatty liver. Given that liver
iron loading is a common feature in human fatty liver disease [8],
the observations that fructose and HFCS increased iron uptake in
our in vitro models of both gut and liver suggests that these
carbohydrates may have an important pathological role.
Under normal conditions the majority of circulating iron is
bound to the plasma iron transport protein transferrin [68],
however blood levels of 0 – 1mmol/L non-transferrin bound iron
(NTBI) may occur post-prandially [69]. Furthermore, NTBI levels
may reach 1 – 20 mmol/L in iron overload disorders as well as in
other chronic diseases such as liver cirrhosis [70]. NTBI is a
heterogeneous mix of compounds; studies suggest that the main
form of plasma NTBI is iron(III)citrate [71], for this reason FAC is
an appropriate model for plasma NTBI. Interestingly, hepatocyte
uptake of NTBI, as opposed to transferrin iron uptake, does not
appear to be inhibited by increasing levels of liver iron [72,73];
fructose mediated liver NTBI uptake may thus escape regulation.
In conclusion, we have shown that fructose and HFCS-55
increase iron bioavailability in human intestinal epithelial cells
and, furthermore, that fructose increases iron-induced hepatic
ferritin levels. Given that substantial amounts of these carbohy-
drates are present in the modern diet, and also their use in
experimental models, these effects may be important in the context
of iron homeostasis. Further studies are warranted to examine if
these in vitro effects translate into (patho)physiologically relevant
changes in animal and human iron status.
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